Related Experiment Video
Updated: Jun 4, 2025
Mesenchymal Stromal Cell Culture and Delivery in Autologous Conditions: A Smart Approach for Orthopedic Applications
Published on: December 8, 2016
Clinical updates in mesenchymal stromal cell therapy for osteoarthritis treatment
1Department of Orthopedics, Dongguk University Ilsan Hospital, Goyang, Republic of Korea.
Introduction:
Osteoarthritis (OA) is a common chronic musculoskeletal disease with heterogeneous clinical manifestations and variable responses to different treatments. Unfortunately, there is no effective disease modifying therapy at present that can alter the natural course of the disease. Cell therapy based on mesenchymal stromal cells (MSCs) may offer an attractive therapeutic option for OA with their multiple modes of action, particularly immune-regulatory and regenerative capacities.
Areas Covered:
In this narrative review, updates on mode of action based on patient's data, factors that can influence the efficacy of MSC treatment, current status in clinical application of MSCs as seen from randomized, controlled OA trials are introduced as well as the author's perspectives in the future of MSCs as OA therapeutics.
Expert Opinion:
Symptomatic relief is not sufficient to justify the high cost associated with culture-expanded stem cells. Its advantages and efficacy over simple and low risk/cost modalities should be seriously reevaluated. Also, as the short-term strategy, efforts should be made to lower the cost of MSC therapy. In the future, multiomics technology may help to predict that subgroup of patients who will favorably respond to stem cell treatment, which would enhance the cost effectiveness and therapeutic benefit of MSC therapy.
Insights
Mesenchymal stromal cells (MSCs) show promise for osteoarthritis (OA) treatment due to their regenerative and immune-regulatory properties. Future research should focus on cost-effectiveness and identifying patient subgroups likely to benefit from MSC therapy.
Area of Science:
- Regenerative Medicine
- Immunology
- Orthopedics
Background:
- Osteoarthritis (OA) is a prevalent chronic musculoskeletal condition with diverse clinical presentations and treatment responses.
- Current treatments for OA lack disease-modifying capabilities, highlighting the need for novel therapeutic strategies.
- Mesenchymal stromal cells (MSCs) present a potential therapeutic avenue for OA, owing to their immune-regulatory and regenerative functions.
Purpose of the Study:
- To review the current understanding of MSCs' mode of action in OA based on patient data.
- To explore factors influencing MSC treatment efficacy and the status of MSCs in clinical OA trials.
- To provide expert perspectives on the future of MSCs as OA therapeutics.
Main Methods:
- Narrative review of existing literature.
- Analysis of data from randomized, controlled OA trials involving MSCs.
- Synthesis of expert opinions on MSC therapy for OA.
Main Results:
- MSC therapy offers potential for OA management through immune modulation and tissue regeneration.
- Factors influencing MSC efficacy and patient selection require further investigation.
- Current clinical trial data provides insights into the application of MSCs for OA.
Conclusions:
- While MSCs hold promise for OA, their high cost necessitates reevaluation against simpler treatments.
- Reducing MSC therapy costs and utilizing multiomics to predict patient response are crucial for enhancing cost-effectiveness and therapeutic benefit.
- Personalized approaches leveraging multiomics may optimize MSC treatment outcomes for specific OA patient subgroups.
More Related Videos
Related Concept Videos
01:19Mesenchymal Stem Cells
01:21Stem Cell Therapy for Tissue Regeneration
Types of Stem Cells used in Stem Cell Therapy
The two main cell...